This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free ...

Tsingke, a provider of integrated life science research solutions, participated in the Antibody Industrial Symposium (AIS) 2026, one of Europe's ...

Tsingke, a provider of integrated life science research solutions, participated in the Antibody Industrial Symposium (AIS) ...

The Singapore state investment company said the rise brought the growth in its China exposure over the past decade to about ...

Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...

One of the questions I get more than any other is, “Jonathan, how do you know these stocks will explode when you find them?” The honest answer is, I don’t. Nobody knows ahead of time that a stock is ...

Indian biotech startups are increasingly finding initial customers abroad, leveraging global markets for faster innovation ...

Mount Sinai physician joins Northwell as chief biotechnology officer, leading biotech strategy and intellectual property at ...

The rapid development of China’s RAS-targeted cancer drugs could reshape global oncology and unlock the country’s undervalued ...

MAIA recently announced that it has completed international enrollment in Part C of the Phase 2 THIO-101 expansion trial. Treatment with ateganosine followed by cemiplimab has shown an acceptable ...

Satellos Bioscience has shared evidence that its Duchenne muscular dystrophy (DMD) drug candidate is active in adults, ...

UK IPO proceeds trebled in H1 2026, according to EY. With easyJet, ITV and a record M&A pipeline, here’s whether London is ...